![New Clinical Guidelines: Distinguishing Variations of Progressive Supranuclear Palsy - Neurology Advisor New Clinical Guidelines: Distinguishing Variations of Progressive Supranuclear Palsy - Neurology Advisor](https://www.neurologyadvisor.com/wp-content/uploads/sites/10/2018/12/progressivesupranuclearpalsy_1227568.jpg)
New Clinical Guidelines: Distinguishing Variations of Progressive Supranuclear Palsy - Neurology Advisor
![Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors | Article Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors | Article](https://assets.cureus.com/uploads/figure/file/212710/lightbox_aa4b7b40b1e611eb90a7718fc86ee1e6-Figure-1_900-revised.png)
Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors | Article
![Alzheimer's Society on Twitter: "For this week's #WednesdayWisdom, we're looking at progressive supranuclear palsy (PSP). This rare condition causes problems with movement, & about 7/10 people with PSP are likely to develop Alzheimer's Society on Twitter: "For this week's #WednesdayWisdom, we're looking at progressive supranuclear palsy (PSP). This rare condition causes problems with movement, & about 7/10 people with PSP are likely to develop](https://pbs.twimg.com/media/E_T-a9UUUAIyDaW.jpg)
Alzheimer's Society on Twitter: "For this week's #WednesdayWisdom, we're looking at progressive supranuclear palsy (PSP). This rare condition causes problems with movement, & about 7/10 people with PSP are likely to develop
![Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology](https://www.thelancet.com/cms/attachment/b9929c37-31a7-42f0-af39-a43445af5dd4/gr2_lrg.jpg)
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology
![Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2000991967/2003662023/gr1.jpg)
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - The Lancet Neurology
![18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty | Scientific Reports 18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-76339-0/MediaObjects/41598_2020_76339_Fig1_HTML.png)
18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty | Scientific Reports
![How to spot ocular abnormalities in progressive supranuclear palsy? A practical review | Translational Neurodegeneration | Full Text How to spot ocular abnormalities in progressive supranuclear palsy? A practical review | Translational Neurodegeneration | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40035-019-0160-1/MediaObjects/40035_2019_160_Fig1_HTML.png)
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review | Translational Neurodegeneration | Full Text
![Prospective Characterization of Progressive Supranuclear Palsy in a Multi-Ethnic Asian Cohort | medRxiv Prospective Characterization of Progressive Supranuclear Palsy in a Multi-Ethnic Asian Cohort | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/10/07/2022.10.01.22280553/F1.large.jpg)
Prospective Characterization of Progressive Supranuclear Palsy in a Multi-Ethnic Asian Cohort | medRxiv
![Brain Sciences | Free Full-Text | Magnetic Resonance Planimetry in the Differential Diagnosis between Parkinson’s Disease and Progressive Supranuclear Palsy Brain Sciences | Free Full-Text | Magnetic Resonance Planimetry in the Differential Diagnosis between Parkinson’s Disease and Progressive Supranuclear Palsy](https://pub.mdpi-res.com/brainsci/brainsci-12-00949/article_deploy/html/images/brainsci-12-00949-g001.png?1658303729)
Brain Sciences | Free Full-Text | Magnetic Resonance Planimetry in the Differential Diagnosis between Parkinson’s Disease and Progressive Supranuclear Palsy
![Progressive Supranuclear Palsy in a Patient with Progressive Nonfluent Aphasia. Ophthalmology Grand Rounds Progressive Supranuclear Palsy in a Patient with Progressive Nonfluent Aphasia. Ophthalmology Grand Rounds](http://webeye.ophth.uiowa.edu/eyeforum/cases-i/case155/1-Progressive-Supranuclear-Palsy.jpg)
Progressive Supranuclear Palsy in a Patient with Progressive Nonfluent Aphasia. Ophthalmology Grand Rounds
![Frontiers | Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism Frontiers | Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism](https://www.frontiersin.org/files/MyHome%20Article%20Library/804385/804385_Thumb_400.jpg)
Frontiers | Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism
![PDF] Exodeviated Ophthalmoplegia in a Patient with Progressive Supranuclear Palsy | Semantic Scholar PDF] Exodeviated Ophthalmoplegia in a Patient with Progressive Supranuclear Palsy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70f03e74533fb7ca79fc1e8c9eb175daa3c0d18a/2-Figure1-1.png)